3 big reasons to stay away from BP plc

Roland Head looks at Q1 figures from BP plc (LON:BP) and points out some potential headwinds for investors.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Oil giant BP (LSE: BP) edged higher today after reporting a first-quarter underlying replacement cost profit of $1.5bn, beating consensus forecasts of $1.26bn. The quarterly dividend was left unchanged at 10 cents per share, suggesting that the group’s forecast yield of 6.9% remains safe for now.

Today’s figures suggest that the group’s recovery from the oil market crash and the Deepwater Horizon disaster is continuing. When I last wrote about BP in March, I suggested it could beat the FTSE 100 in 2017, as it has done over the last year.

I still view BP as a reasonable long-term income holding for oil and gas exposure, but I’ve since sold my shares in this firm. I’ve started to focus more heavily on the potential risks for investors in BP, and believe that better buys are available elsewhere.

Debt keeps rising

BP’s net debt was $38.6bn at the end of March, an increase of almost 9% from $35.5bn at the end of 2016.

The group is ramping up spending to rebuild its portfolio, which is depleted after years of asset sales following the 2010 Deepwater Horizon disaster. BP’s net debt is now equivalent to 5.6 times the group’s 2017 forecast net profit of $6.8bn. Although this multiple falls to 4.4 times in 2018, this level of gearing still looks high to me.

I believe this amount of borrowing only makes sense if you expect oil prices to rise significantly above current levels. Although I do expect further gains for oil, I’d rather see BP taking a slightly more cautious approach to its borrowings in order to protect future shareholder returns.

Dividend vs earnings

One way BP could slow down debt growth would be to cut the dividend. The group’s generous $0.40 per share payout hasn’t been covered by earnings since 2014 and isn’t expected to be covered this year either.

I estimate that dividend payments may have added about $9bn to BP’s net debt over the last two years. Today’s first-quarter figures show this trend is continuing. Net cash from operating activities of $2.1bn wasn’t nearly enough to cover the group’s investing spend of $3.8bn, and its $1.3bn dividend payout.

In my view, BP’s debts mean the group’s shares are increasingly a bet on the rising price of oil. At 450p, the stock currently trades on a forecast 2017 P/E of 17 and a 2018 P/E of 13. In my view, that’s high enough for the moment.

A chronic underperformer

Some of the comments I’ve made about BP’s dividend and debt choices could also apply to Shell. But for investors, there is one big difference between BP and Shell.

Since 1999, BP stock has lost 3% of its value. During the same period, the FTSE 100 has climbed 18% and the value of Shell’s B shares has risen by 67%.

Shell has outperformed the market by a big margin over the last 18 years, whereas BP has lagged behind. In my opinion, investors looking for a big-cap oil stock to provide a long-term income might do better with Shell than BP.

Roland Head has no position in any shares mentioned. The Motley Fool UK has recommended BP. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »